ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "joint damage"

  • Abstract Number: 533 • 2017 ACR/ARHP Annual Meeting

    Assessment of Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Tofacitinib: Data from an Open-Label Long-Term Extension Study over 3 Years

    Désirée van der Heijde1, Jürgen Wollenhaupt2, Stanley B Cohen3, Sander Strengholt4, Ketti Terry5, Ryan DeMasi6, Kenneth Kwok7, Irina Lazariciu8 and Lisy Wang5, 1Leiden University Medical Center, Leiden, Netherlands, 2Schön-Klinik Hamburg-Eilbek Teaching Hospital of the University of Hamburg, Hamburg, Germany, 3Metroplex Clinical Research Center and University of Texas Southwestern Medical Center, Dallas, TX, 4Pfizer Inc, Capelle aan den IJssel, Netherlands, 5Pfizer Inc, Groton, CT, 6Pfizer Inc, Collegeville, PA, 7Pfizer Inc, New York, NY, 8QuintilesIMS, Saint-Laurent, QC, Canada

    Background/Purpose: Tofacitinib is an oral Janus kinase inhibitor for the treatment of RA. The long-term safety and clinical efficacy of tofacitinib 5 and 10 mg…
  • Abstract Number: 1101 • 2017 ACR/ARHP Annual Meeting

    Systematic Physician Assessment Beyond Inflammation in Routine Rheumatology Care Using Visual Analog Scale Scores for Inflammation, Damage, and Distress to Document Patient Status and Support Clinical Decisions: Analysis of Inter-Rater Reliability

    Shakeel M. Jamal1, Theodore Pincus2, Isabel Castrejón2, Jacquelin R. Chua1, Aman Kugasia1, Juan Schmukler1, Stacy Weinberg1 and Joel A. Block3, 1Division of Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Rush University Medical Center, Chicago, IL, 3Rush University Medical Center, Chicago, IL

    Background/Purpose: A physician global estimate of patient status (DOCGL) on a 0-10 visual analog scales (VAS) is as effective as any rheumatoid arthritis (RA) Core…
  • Abstract Number: 1366 • 2017 ACR/ARHP Annual Meeting

    Evaluation of Synovial Fluid 14-3-3η Protein As a Marker of Joint Damage in Rheumatoid Arthritis Patients

    Nevin Hammam1,2, Shaimaa Salah3, Anthony Marotta4 and Emad F. Kholef5, 1Rheumatology and Rehabilitation Department, University of Assiut, Assiut, Egypt, 2University of Alberta, Edmonton, AB, Canada, 3Rheumatology, Rehabilitation and Physical Medicine department, Faculty of Medicine, Assiut, Assiut, Egypt, 4Augurex Life Sciences Corp., Vancouver, BC, Canada, 5Clinical Pathology Department, Aswan University Hospital, Aswan, Egypt

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory disease that results in severe joint damage and physical disability, therefore, the discovery of new marker(s) for…
  • Abstract Number: 2245 • 2017 ACR/ARHP Annual Meeting

    The Effects of Structural Damage on Functional Disability in Psoriatic Arthritis

    Andreas Kerschbaumer1, Gabriela Supp1, Josef S. Smolen1,2 and Daniel Aletaha1, 1Medical University Vienna, Division of Rheumatology, Department of Internal Medicine III, Vienna, Austria, 22nd Department of Medicine, Hietzing Hospital, Vienna, Austria

    Background/Purpose: Functional outcomes are central in patients with chronic inflammatory musculoskeletal diseases. In a secondary data analysis of the GO-REVEAL trial we investigated if structural…
  • Abstract Number: 2300 • 2017 ACR/ARHP Annual Meeting

    Predictive Value of Magnetic Resonance Imaging in Patients with Juvenile Idiopathic Arthritis in Clinical Remission

    Clara Malattia1, Marta Mazzoni Sr.2, Stefania Viola Sr.2, Angela Pistorio3, Francesca Magnaguagno4, Alessia Urro Jr.2, Angelo Ravelli5 and Alberto Martini6, 1Pediatria2 Reumatologia, Istituto Giannina Gaslini, Genoa, Italy, 2Pediatria 2 Reumatologia, Istituto Giannina Gaslini, Genova, Italy, 3Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, Genoa, Italy, 4UO Radiologia, Istituto Giannina Gaslini, Genoa, Italy, 5University of Genova, IRCCS Istituto Giannina Gaslini, Genova, Italy, 6Istituto Giannina Gaslini, Genoa, Italy

    Background/Purpose: MRI studies on RA revealed that subclinical synovitis is common in patients in clinical remission and it is responsible for structural damage progression. MRI-detected…
  • Abstract Number: 2458 • 2017 ACR/ARHP Annual Meeting

    Tocilizumab Inhibits Progression of Erosive Joint Damage in Early Rheumatoid Arthritis More Effectively Than Step-up Methotrexate Therapy

    Xavier M Teitsma1, Johannes WG Jacobs1, Paco MJ Welsing2, Attila Pethö-Schramm3, Michelle EA Borm4, Jacob M. van Laar5, Floris PJ Lafeber5 and Johannes W.J. Bijlsma2, 1Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3F. Hoffmann-La Roche, Basel, Switzerland, 4Beneluxlaan 2a, Roche Nederland BV, Woerden, Netherlands, 5Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: In early rheumatoid arthritis (RA), starting therapy as soon as possible is important to reduce disease activity and preserve the joints. With application of…
  • Abstract Number: 945 • 2016 ACR/ARHP Annual Meeting

    When and Where Musculoskeletal Ultrasound Might Replace Magnetic Resonance in the Assessment of Patients with Juvenile Idiopathic Arthritis?

    Stefano Lanni1, Francesca Magnaguagno2, Erica Ricci3, Angela Pistorio4, Cecilia Bava1, Alberto Martini5 and Clara Malattia6, 1Pediatria 2 Reumatologia, Istituto Giannina Gaslini, Genoa, Italy, 2UO Radiologia, Istituto Giannina Gaslini, Genoa, Italy, 3Istituto G. Gaslini, Pediatria 2 -Reumatologia, genova, Italy, 4Pediatria II, Reumatologia, PRINTO, Istituto Giannina Gaslini, Genoa, Italy, 5PRINTO-IRCCS, Genova, Italy, 6Pediatria2 Reumatologia, Istituto Giannina Gaslini, Genoa, Italy

    Background/Purpose: Magnetic resonance imaging (MRI) is the most attractive imaging modality for the investigation of patients with juvenile arthritis (JIA). Musculoskeletal ultrasound (MSUS) has intuitive…
  • Abstract Number: 1111 • 2016 ACR/ARHP Annual Meeting

    Huntingtin Interactin Protein 1 (HIP1) Regulates Receptor Tyrosine Kinases Mediated Activity and Cell Invasiness in Fibroblast-like Synoviocytes

    Teresina Laragione, Nasim Azizgolshani, Carolyn Harris, Erjing Gao and Percio Gulko, Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Huntingtin-interacting protein 1 (Hip1) is a new arthritis severity gene recently identified in the Pristane and Collagen-induced arthritis (PIA, CIA) quantitative trait locus Cia25/Pia42…
  • Abstract Number: 1791 • 2016 ACR/ARHP Annual Meeting

    Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia

    John P. Case1, Heidi Tucker2 and Congbin Wang3, 1Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Rush Medical College, Chicago, IL, 3Internal medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

    Background/Purpose:   The elbow extension angle (ELB) is commonly given as 180o although most healthy females exhibit hyperextension(1).  The loss of hyperextension (LOH) in a…
  • Abstract Number: 2489 • 2016 ACR/ARHP Annual Meeting

    Joint Damage Appears As Severe As Inflammation According to Physician Visual Analog Scales in Patients with Rheumatoid Arthritis Regardless of Disease Severity at 2 Sites, Which May Limit Results of a Treat-to-Target Strategy

    Theodore Pincus1, Isabel Castrejón1, Kathryn Gibson2 and Joel Block3, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Liverpool Hospital and University of New South Wales, Liverpool, Australia, 3Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: A physician estimate of global status (DOCGL) on a 0-10 visual analog scale (VAS) was developed initially to assess inflammation in patients with rheumatoid…
  • Abstract Number: 3124 • 2016 ACR/ARHP Annual Meeting

    Huntingtin Interacting Protein 1 (Hip1) Is a New Arthritis Severity Gene

    Teresina Laragione1, Percio Gulko1 and Max Brenner2, 1Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, 2Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose:  Cia25/Pia42 is an arthritis severity and joint damage quantitative trait locus on rat chromosome 12 previously identified in an intercross between MHC identical but…
  • Abstract Number: 3157 • 2016 ACR/ARHP Annual Meeting

    The Association Between Sonographic Enthesitis and Radiographic Damage in Psoriatic Arthritis

    Ari Polachek1, Dafna D Gladman2, Richard J. Cook3, Vinod Chandran4 and Lihi Eder5, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, 4Rheumatology, University of Toronto, Toronto, ON, Canada, 5Medicine, University of Toronto, Women's College Hospital, Toronto, ON, Canada

    Background/Purpose: Enthesitis is a common clinical finding and a key pathogenic feature in psoriatic arthritis (PsA). Ultrasound is emerging as a preferred method to assess…
  • Abstract Number: 135 • 2015 ACR/ARHP Annual Meeting

    Limitations of Treat-to-Target in Rheumatoid Arthritis: Joint Damage Appears As Severe As Inflammation in Contemporary Care at One Site

    Theodore Pincus1, Alex D. Luta2, Isabel Castrejón1, Annie Huang1, Ruchi Jain1, Sarah L. Everakes3 and Joel A. Block4, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Georgetown University, Washington, DC, 3Internal Medicine, Rush University Medical Center, Chicago, IL, 4Rush University Medical Center, Chicago, IL

    Background/Purpose: Treatment of rheumatoid arthritis is directed to “treat-to-target,” with intensification of therapy in patients with moderate/high disease activity according to a quantitative index toward…
  • Abstract Number: 509 • 2015 ACR/ARHP Annual Meeting

    In Early Undifferentiated Polyarthritis, 14-3-3η Seroreversion or Sustained Negativity Is Associated with Better Radiographic Outcomes, Even in DAS-28 Remitters

    Gilles Boire1,2, Nathalie Carrier3, Artur de Brum-Fernandes1,4, Patrick Liang1,4, Ariel Masetto2,5, Yuan Gui6, Jane Savill6, Sara Michienzi6, Henri Ménard7, Walter Maksymowych8 and Anthony Marotta6, 1Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada, 2Department of Medicine/Division of Rheumatology, University of Sherbrooke, Sherbrooke, QC, Canada, 3Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Sherbrooke, QC, Canada, 5Department of Medicine/Division of Rheumatology, Université de Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada, 6Augurex Life Sciences Corp., Vancouver, BC, Canada, 7MSK Research Axis, McGill University Health Center Research Institute, Montreal, QC, Canada, 8Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Advancements in RA treatment approaches with DMARDs and biological agents have enabled disease remission goals that were previously considered unattainable. The concept of "tight…
  • Abstract Number: 513 • 2015 ACR/ARHP Annual Meeting

    Cumulative Association of Genetic Variants with Rheumatoid Joint Damage Progression in Mexican Americans and European Americans

    Rector Arya1, Inmaculada del Rincon2, Jose Felix Restrepo3, Vidya S Farook4, Christopher P Jenkinson5, Ravindranath Duggirala6 and Agustin Escalante7, 1Pediatrics, University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, 3Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 4Genetics, Texas Biomedical Research Institute, San Antonio, TX, 5University of Texas Health Science Center at San Antonio, San Antonio, TX, 6Regional Academic Health Center, Harlingen, TX, 7Dept. of Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX

    Background/Purpose: Genealogical and genetic association studies have suggested that joint damage in rheumatoid arthritis (RA) may be heritable. We and others have found a number…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology